Article Information
History
- September 1, 2021.
Article Versions
- Version 1 (June 3, 2021 - 10:30).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Chansavath Phetsouphanh1,*,#,
- David Darley2,*,
- Daniel B Wilson3,
- Annett Howe1,
- C. Mee Ling Munier1,
- Sheila K Patel4,
- Jennifer A Juno5,
- Louise M Burrell4,
- Stephen J Kent5,6,
- Gregory J Dore1,2,
- Anthony D Kelleher1,2,†,# and
- Gail V Matthews1,2,†,#
- 1The Kirby institute, University of New South Wales, NSW 2033, Australia
- 2St Vincent’s Hospital, Darlinghurst, NSW 2010, Australia
- 3Department of Mathematics and Statistics, Boston University, MA 02215, United States of America
- 4Department of Medicine, Austin Health, University of Melbourne, Victoria 3084, Australia
- 5Department of Microbiology and Immunology, Peter Doherty Institute, University of Melbourne, Victoria 3000, Australia
- 6Melbourne Sexual health centre, Infectious Diseases Department, Alfred health, central Clinical School, Monash University, Melbourne, Victoria 3004, Australia
- ↵#Correspondence Dr Chansavath Phetsouphanh, cphetsouphanh{at}kirby.unsw.edu.au, Prof. Anthony Kelleher, akelleher{at}kirby.unsw.edu.au, Prof. Gail Matthews, gmatthews{at}kirby.unsw.edu.au
↵*, † These authors contributed equally
Posted September 01, 2021.
Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection
